Intrinsic Value of S&P & Nasdaq Contact Us

Exact Sciences Corporation EXAS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
$2,183.66
+1981.5%
Analyst Price Target
$103.18
-1.6%

Stock Statistics — EXAS

Exact Sciences Corporation (EXAS) has a market capitalization of $20.03B and trades at $104.91. The 52-week range is 38.81-104.98.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -95.4, Earnings Per Share (EPS) of $-1.10, annual revenue of $3.25B.

The stock has a beta of 1.44, operates in the Healthcare sector.

Trading Data
Current Price$104.91
52-Week Range38.81-104.98
Volume21.56M
Avg Volume (30D)2.53M
Market Cap$20.03B
Beta (1Y)1.44
Company
IPO Date2001-02-01
Employees6,900
CEOKevin T. Conroy
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS30063P1057
CUSIP30063P105
Income (Latest Year)
Revenue$3.25B
Gross Profit$2.26B
EBITDA$122.5M
Operating Income$-99.08M
Net Income$-207.95M
EPS$-1.10
EPS Diluted$-1.10
Shares Outstanding$188.69M
Balance Sheet (Latest Year)
Total Assets$5.86B
Current Assets$1.56B
Cash & ST Investments$964.71M
Total Liabilities$3.46B
Total Debt$2.52B
Net Debt$1.57B
Total Equity$2.4B
Debt / Equity1.05
Valuation Ratios
P/E Ratio-95.4
P/S Ratio6.17
P/B Ratio8.34
EV/EBITDA (approx)163.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message